Sign In
Buy SGPYY
$42.52
+0.0600 (+0.141%)
At Close: Jun 23, 2026
Stockholder Notice: Robbins LLP Informs Stockholders of the Class Action Filed Against Sage Therapeutics, Inc.
03:37pm, Thursday, 29'th Aug 2024
SAN DIEGO, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Sage Ther
Sage Therapeutics Inc. Is Being Inquired Into For Securities Impropriety And The Schall Law Firm Wants Impacted Investors To Reach Out
11:00am, Thursday, 29'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeuti
Pomerantz Law Firm Announces the Filing of a Class Action Against Sage Therapeutics, Inc. and Certain Officers – SAGE
10:00pm, Wednesday, 28'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Sage Therapeutics, Inc. ("Sage" or the "Company") (NASDAQ:SAGE) and certain off
LOS ANGELES, CA / ACCESSWIRE / August 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeuti
BEAUFORT, S.C.--(BUSINESS WIRE)-- #CLIFighters--Research published by THE SAGE GROUP examines the prevalence, characteristics, comorbidities and consequences of BTA disease, as well as explores the ch
The Schall Law Firm Is Looking Into Possible Securities Infractions By Sage Therapeutics Inc And Investors Are Urged To Participate
11:00am, Tuesday, 27'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeuti
Meta strikes geothermal energy deal with Sage Geosystems to power data centers
01:08pm, Monday, 26'th Aug 2024
Facebook owner Meta Platforms struck a deal to buy up to 150 MW of geothermal power from Sage Geosystems to supply its data centers, as it races to build out the infrastructure to support its massive
Sage Geosystems and Meta Announce Agreement for Next-Generation Geothermal Power Generation
01:00pm, Monday, 26'th Aug 2024
WASHINGTON--(BUSINESS WIRE)--Today, at the U.S. Department Energy's (DOE) Catalyzing Next Generation Geothermal Development Workshop, Sage Geosystems (Sage) and Meta Platforms, Inc (Meta) announced a
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or "the Company") (NASDAQ:SAGE)
LOS ANGELES, CA / ACCESSWIRE / August 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeuti
The Schall Law Firm Is Inquiring Into Sage Therapeutics Inc For Securities Fraud And Stockholders Are Invited To Play A Part
11:00am, Saturday, 24'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeuti
Sage Therapeutics Inc Is Being Looked Into By The Schall Law Firm For Securities Law Violations And Investors Are Asked To Join
11:00am, Friday, 23'rd Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeuti
LOS ANGELES, CA / ACCESSWIRE / August 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeuti
LOS ANGELES, CA / ACCESSWIRE / August 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeuti
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sage Therapeutics, Inc. - SAGE
12:45pm, Monday, 19'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 19, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") (NASDAQ:SAGE). Such investors are advise
